FDA said on April 16 that it is revoking the emergency use authorization (EUA) for bamlanivimab—when administered alone—to be used for treatment of mild to moderate COVID-19 in adults and certain pediatric patients. 

More than 87,000 Americans died from drug overdoses in the 12-month period that ended in September 2020, according to preliminary CDC data, which indicate that the U.S. drug overdose mortality rate increased last year.

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson, J&J) vaccine remains in place.

Direct oral anticoagulants (DOACs) are associated with better outcomes than warfarin among patients with valvular atrial fibrillation (AF), according to a study published on March 30, 2021 in the Annals of Internal Medicine.

The list of medication options to treat patients who have diabetes grows continually longer and longer. A new clinical practice review article published April 1 by Rita Rastogi Kalyani, MD, in The New England Journal of Medicine (NEJM), distills the newest trial results and guidelines into a systematic approach for the treatment of patients with diabetes.